Investigator Initiated
FDG-PET in Cancer Associated Venothromboembolism (VTE)
FDG-PET/CT in the Evaluation of Persistent Ffebrile Nneutropenia in Cancer Patients (HCI 22418)
A Multi-Modality Imaging Assessment of Chemobrain (HCI 21946)
Sunitinib for Metastatic Renal Cell Cancer with Imaging Biomarker Assessments for the Early Prediction of Tumor Response (HCI 21897)
Development of an Integrated Molecular Biomarker of Early Prediction of Therapeutic Response to Targeted Therapy in Stage IIIB/IV or Recurrent Lung Cancer Patients using Imaging Assessments and Genomic Modeling (HCI26198)
Multi-Tracer PET Assessment of Primary Brain Tumors: Pilot Study and Technology Development
Industry Sponsored Clinical Trials
